Quarterly report [Sections 13 or 15(d)]

Equity Incentive Plans

v3.25.1
Equity Incentive Plans
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
The Company has outstanding awards granted under four equity compensation plans: the 2021 Equity Incentive Plan, as amended (the “Plan”), the Aurora Innovation, Inc. 2017 Equity Incentive Plan (the “2017 Plan”), the Blackmore Sensors & Analytics, Inc. 2016 Equity Incentive Plan (the “Blackmore Plan”), and the OURS Technology Inc. 2017 Stock Incentive Plan, as amended (the “OURS Plan”). The Company assumed awards under the 2017 Plan, the Blackmore Plan and the OURS Plan to the extent such employees continued as employees of the Company.
Under the Plan, equity-based compensation in the form of restricted stock units (“RSUs”), restricted stock awards, incentive stock options, non-qualified stock options, stock appreciation rights, and performance units may be granted to employees, officers, directors, consultants, and others. As of March 31, 2025, there were 264 million shares available for grant under the Plan.
Stock-based Compensation Expense
Stock-based compensation is allocated on a departmental basis, based on the classification of the option holder or grant recipient. No income tax benefits have been recognized in the statement of operations for stock-based compensation arrangements and no stock-based compensation has been capitalized as of March 31, 2025.
Total stock-based compensation expense by function was as follows (in millions):
Three Months Ended
March 31,
2025 2024
Research and development
 $ 29  $ 31 
Selling, general, and administrative
 5  5 
Total
 $ 34  $ 36 
Restricted Stock Units
RSUs granted under the Plan generally are subject to a time-based vesting requirement. Generally, the time-based vesting requirement is quarterly over one to four years starting on the vesting commencement date, with a one-year cliff vesting for new hire awards.
RSU activity under the Plan and the 2017 Plan was as follows (in millions, except per share amounts):
Number of
shares		 Weighted-
average grant
date fair value
Unvested at December 31, 2024
 76  $ 2.67 
Granted
 39  7.77 
Vested (11) 2.66 
Forfeited
 (4) 2.27 
Unvested at March 31, 2025
 100  $ 4.64 
The unrecognized stock-based compensation related to unvested RSUs was $447 million at March 31, 2025 and will be recognized over a weighted average period of 2.9 years. The fair value of RSUs as of their respective vesting dates was $88 million for the three months ended March 31, 2025.
Stock Options
The exercise price of stock options granted under the Plan and the 2017 Plan may not be less than 100% of the fair value of the Company’s common stock on the date of the grant. Stock options generally vest over one to four years starting on the vesting commencement date and expire, if not exercised, 10 years from the date of grant or, if earlier, three months after the option holder ceases to be a service provider of the Company. Stock options outstanding under the Blackmore Plan and the OURS Plan are not material.
Stock options granted under the Plan during the three months ended March 31, 2025 were as follows:
Three Months Ended
March 31, 2025
Stock options granted (in millions) 2 
Weighted average grant date fair value $ 6.48 
Weighted average grant date fair value assumptions:
Expected term
 6.2 years
Risk-free interest rates
 4.3  %
Expected volatility 88.8  %
Stock option activity under the Plan and the 2017 Plan was as follows (in millions, except per share amounts):
Number of
shares		 Weighted
average
exercise price		 Weighted average remaining contractual term (in years) Aggregate intrinsic value
Outstanding at December 31, 2024
 117  $ 2.07 
Granted 2  8.47 
Exercised
 (8) 2.09 
Forfeited
 (3) 1.97 
Outstanding at March 31, 2025
 108  $ 2.18  7.4 $ 492 
Exercisable at March 31, 2025
 62  $ 1.80  6.4 $ 301 
The unrecognized stock-based compensation related to unvested stock options was $69 million as of March 31, 2025 and will be recognized over a weighted average period of 2.6 years. The intrinsic value of stock options exercised was $44 million for the three months ended March 31, 2025.